The Effect of Impaired Hepatic Function on the Pharmacokinetics of LY2216684.
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2013
At a glance
- Drugs Edivoxetine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- 04 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 11 Mar 2011 Planned end date changed from 1 May 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.
- 24 Nov 2010 New trial record